6609 — Shanghai HeartCare Medical Technology Balance Sheet
0.000.00%
- HK$1.81bn
- HK$1.07bn
- CNY277.90m
- 54
- 23
- 91
- 60
Annual balance sheet for Shanghai HeartCare Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 632 | 1,218 | 870 | 721 | 714 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.19 | 24.5 | 34.7 | 87 | 98.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 662 | 1,332 | 1,132 | 1,005 | 1,024 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 52.4 | 112 | 118 | 139 | 118 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 774 | 1,505 | 1,313 | 1,201 | 1,206 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 36.6 | 55.4 | 67.5 | 59.8 | 82.4 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 92.3 | 132 | 147 | 126 | 144 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 681 | 1,373 | 1,165 | 1,076 | 1,062 |
| Total Liabilities & Shareholders' Equity | 774 | 1,505 | 1,313 | 1,201 | 1,206 |
| Total Common Shares Outstanding |